CL25216
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CL25216, covering 2025-12-05 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of CL25216 on Hormonal Balance and Menstrual Health in Women With Primary Dysmenorrhea. [NA]